Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label single-arm study of brivaracetam tablets for partial seizures
ChiCTR2600131644Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in epilepsy and Focal onset seizure, sponsored by West China Hospital of Sichuan University. Primary endpoints: Incidence of adverse events and serious adverse events and Proportion of subjects who withdrew from the trial due to adverse events. Started Feb 2025; status: recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on ChiCTR2600131644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131644.